NHS and rechargeables resist upward trend in UK and ROI hearing instrument sales Q3

Q3 2024 figures released by the British Irish Hearing Instrument Manufacturers Association (BIHIMA) reveal a continuing upward trend in overall hearing instrument sales in the UK and ROI. But sales of NHS units, which have climbed steadily since the pandemic, suddenly hit a wall. [caption id="attachment_139299" align="alignright" width="300"] BIHIMA[/caption] And for the first time, the march of rechargeable devices has been halted. Commenting on the slight dip in UK non-NHS rechargeable figures from Q2 at 88.9% to 88.5% in Q3, and the bigger fall in ROI from 56.6% Q2 to 47.1% Q3, BIHIMA Chairman Paul Surridge said: "It’s a surprise to see a drop in rechargeable hearing instrument sales because these have remained on a steady rise up until Q3. Time will tell how this situation develops as...